Please note, from 2022 the Print ISSN is not in active use as this journal is no longer published in print.

Cancer Biology & Therapy is a high-profile international journal examining all aspects of the molecular basis of cancer, with translational relevance to diagnosis and therapy. The goal is to foster communication and the rapid exchange of information through timely publication of important advances within the field.

Topics covered include:

    Existing and emerging technologies such as genome sequencing to increase understanding of genomic and proteomic alterations occurring within tumors;
    Tumor pathogenesis, development and progression;
    Drug-drug interactions; mechanisms of action for novel agents; combination chemotherapy;
    Pharmacogenomics, pharmacodynamics, and pharmacokinetic properties of anticancer agents;
    Anticancer chemotherapeutic agents, biological agents, immunomodulatory drugs, cell therapy and gene therapy.

The journal publishes original research, reviews, meeting reports, bedside-to-bench reports, letters to the editor, and perspective articles.

Cancer Biology & Therapy operates a single-anonymized peer review policy.

*Please note that Cancer Biology & Therapy converted to a full Open Access journal from Volume 23 (2022).

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.